Furthermore, in the frontal cortex of patients with AD and AD mice, the levels of phosphorylated Ser726-Add1 are increased, which are accompanied by an increase in Rock2 expression (Fig. 5f, Supplementary Fig. 4j, k). Here, ADD1 is linked to Alzheimer disease.